BLOODCANCERSTODAY.COM KEYWORD DENSITY CHECKER

Total words: 4487 | 2-word phrases: 1163 | 3-word phrases: 1331 | 4-word phrases: 1392

PAGE INFO

Title Try to keep the title under 60 characters (47 characters)
Hematologic Oncology News | Blood Cancers Today
Description Try to keep the meta description between 50 - 160 characters (177 characters)
Blood Cancers Today provides hematologists and oncologists with news, education, and information relevant to their patients and practices, featuring exclusive expert interviews.
Keywords Meta keywords are not recommended anymore (0 characters)
H1 No H1 tag on the page (0 characters)

ONE WORD PHRASES 601 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1and467.65%
2the396.49%
3of335.49%
4in335.49%
5md315.16%
6with233.83%
7leukemia183.00%
8news172.83%
9for172.83%
10patients152.50%

TWO WORD PHRASES 1163 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1cell lymphoma121.03%
2patients with100.86%
3website logo90.77%
4the hemonc90.77%
5hemonc pulse90.77%
6listen now80.69%
7the latest70.60%
8chadi nabhan70.60%
9myeloid leukemia70.60%
109 202470.60%
11in patients70.60%
12nabhan md60.52%
13of the60.52%
14bcell lymphoma60.52%
15mba facpthe60.52%
16facpthe hemonc60.52%
17md mba60.52%
18prognostic model50.43%
19annual meeting50.43%
20acute myeloid50.43%

THREE WORD PHRASES 1331 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1the hemonc pulse90.68%
2in patients with70.53%
3facpthe hemonc pulse60.45%
4mba facpthe hemonc60.45%
5md mba facpthe60.45%
6nabhan md mba60.45%
7chadi nabhan md60.45%
8acute myeloid leukemia50.38%
9acute lymphoblastic leukemia40.30%
10the latest news40.30%
11aggressive bcell lymphoma40.30%
12chronic lymphocytic leukemia40.30%
13cailin connermyelofibrosisoctober 830.23%
14new prognostic model30.23%
15prognostic model predicts30.23%
16twelfth annual meeting30.23%
17model predicts cns30.23%
18predicts cns relapse30.23%
19cns relapse in30.23%
20two nk receptor30.23%
21delivers the latest30.23%
22relapse in patients30.23%
23nk receptor ligands30.23%
24patients with tcell30.23%
25pediatric patients with20.15%
26patients with chronic20.15%
27guillermo garciamanero md20.15%
28melissa badamoprintoctober 920.15%
29jerald radich md20.15%
30is the leading20.15%

FOUR WORD PHRASES 1392 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1md mba facpthe hemonc60.43%
2mba facpthe hemonc pulse60.43%
3chadi nabhan md mba60.43%
4nabhan md mba facpthe60.43%
5prognostic model predicts cns30.22%
6in patients with tcell30.22%
7relapse in patients with30.22%
8cns relapse in patients30.22%
9model predicts cns relapse30.22%
10predicts cns relapse in30.22%
11new prognostic model predicts30.22%
12delivers the latest news30.22%
13two nk receptor ligands30.22%
14md phd elected soho20.14%
15soho presents named awards20.14%
16with pacritinib versus momelotinib20.14%
17phd elected soho president20.14%
18revumenib for kmt2arearranged acute20.14%
19scheinberg md phd elected20.14%
20phil scheinberg md phd20.14%
21named awards at twelfth20.14%
22with revumenib for kmt2arearranged20.14%
23favorable with revumenib for20.14%
24safety favorable with revumenib20.14%
25remission safety favorable with20.14%
26extended look into longterm20.14%
27look into longterm zoledronic20.14%
28into longterm zoledronic acid20.14%
29longterm zoledronic acid in20.14%
30zoledronic acid in multiple20.14%
31presents named awards at20.14%
32therapy in newly diagnosed20.14%
33awards at twelfth annual20.14%
34models genetic markers in20.14%
35laboratory differences in myelofibrosis20.14%
36genomic laboratory differences in20.14%
37highlights genomic laboratory differences20.14%
38study highlights genomic laboratory20.14%
39mba facpthe hemonc pulseapril20.14%
40cailin connermyelofibrosisoctober 8 2024the20.14%

EXTERNAL LINKS

# URL Whois Check
1https://mashupmd.com/in-multiple-myeloma-monthly-treatment-with-zoledronic-acid-beyond-two-years-offers-sustained-protection-against-progressive-bone-disease/ Whoismashupmd.com
2https://mashupmd.com/cd155-pvr-determines-acute-myeloid-leukemia-targeting-by-delta-one-t-cells/ Whoismashupmd.com
3https://mashupmd.com/fda-approves-bosutinib-for-pediatric-patients-with-chronic-myelogenous/ Whoismashupmd.com
4https://mashupmd.com/minimal-residual-disease-response-adapted-therapy-in-newly-diagnosed-multiple-myeloma-master-final-report-of-the-multicentre-single-arm-phase-2-trial-2/ Whoismashupmd.com
5https://mashupmd.com/drug-shortages-48/ Whoismashupmd.com
6https://cancernursingtoday.com/ Whoiscancernursingtoday.com
7https://mashupmd.com Whoismashupmd.com
8https://guoncologynow.com/ Whoisguoncologynow.com
9https://www.docwirenews.com/ Whoisdocwirenews.com
10https://urbanhealthtoday.com/ Whoisurbanhealthtoday.com
11https://www.docwirenews.com/page/gi-oncology-now Whoisdocwirenews.com
12https://www.docwirenews.com/page/heme-today Whoisdocwirenews.com
13https://www.docwirenews.com/page/lung-cancers-today Whoisdocwirenews.com
14https://www.docwirenews.com/page/nephrology-times Whoisdocwirenews.com
15https://twitter.com/blood_cancers Whoistwitter.com
16https://www.linkedin.com/company/blood-cancers-today/ Whoislinkedin.com
17https://www.youtube.com/channel/UCMuELAEOctLHwJgejoXvJ4w Whoisyoutube.com
18https://mashupmd.com/category/latest-headlines/ Whoismashupmd.com
19https://guoncologynow.com/ Whoisguoncologynow.com
20https://cancernursingtoday.com/ Whoiscancernursingtoday.com
21https://urbanhealthtoday.com/ Whoisurbanhealthtoday.com
22https://www.docwirenews.com Whoisdocwirenews.com
23https://formedics.com/terms-conditions/ Whoisformedics.com
24https://formedics.com/privacy-policy/ Whoisformedics.com